13th International Conference on Environmental Mutagens

Maintaining Genomic Health in a Changing World

52nd Annual Meeting of the EMGS

August 28 - September 2, 2021 - Ottawa Canada




Approximately two-thirds of the program has been developed, with 19 accepted symposia and six confirmed workshops. Thirteen symposia are currently in development. Symposia are an equal balance of applied and basic symposia spanning the specialty areas and are summarized below: 

Developing Integrated Approaches to Testing and Assessment (IATA) Using An Adverse Outcome Pathway (AOP) Framework
Chair: Chris Barber, Lhasa limited, UK

Cancer Genomics Provides Insight Into Cancer Etiology, Progression and Therapeutic Response
Chair: Barbara Parsons, US Food & Drug Administration, National Center for Toxicological Research, Division of Genetic and Molecular Toxicology, USA

How Cells Tolerate and Replicate DNA Damage?
Chair: Carlos FM Menck, Institute of Biomedical Sciences, University of Sao Paulo, Brazil

Using Quantitative Genetic Toxicology to Advance the Assessment of Genotoxic Impurities in Pharmaceuticals
Chair: Dr. George Edward Johnson, Swansea University, UK

From Genomes to Ecosystems: What are the Ecological Consequences of Genotoxicity?
Chair: Jason O’Brien, Environment and Climate Change Canada, Canada

Consequences of Pharmaceuticals and Chemicals for Male and Female Germ Cells
Chair: Jill Escher, Escher Fund for Autism, USA

Carcinogens, Carcinogenesis and Cancer: Application of Artificial Intelligence & Machine Learning
Chair: Luoping Zhang, School of Public Health, University of California, Berkeley, USA

Role of RNA in DNA Repair
Chair: Mats Ljungman, University of Michigan, USA

Genome Editing: Intentional Mutagenesis of the Genome and Implications for Human Health
Chair: P.J. Brooks, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, USA

Genotoxic Hazards of Air Pollution – a Global Perspective
Chair: Paul White, Environmental Health Science and Research Bureau, Health Canada, Canada

R-loop Roadblocks to Transcription and Replication
Chair: Philip C Hanawalt, Department of Biology, Stanford University, USA

Polynucleotide Signatures and Regulation of Genotoxin Stress Response
Chair: Robert W. Sobol, PhD, University of South Alabama, USA

Personalized Cancer Risk and Prevention: Models Integrating Genetics, Infection, Diet, Exercise and Other Factors for Specific Cancers
Chair: Rosalie K. Elespuru, US Food and Drug Administration, Center for Device and Radiological Health, USA

DNA Cross-Link Repair and Health
Chair: Sara Frias, Instituto Nacional de Pediatría/Instituto de Investigaciones Biomédicas, UNAM, México

Risk Assessment of Low-Dose Rate Radiations; Lessons From the Fukushima Nuclear Accident
Chair: Takayoshi Suzuki, Div. Molecular Target and Gene Therapy Products, National Institute of Health Sciences, Japan

Dynamics of Mutation Acquisition in Somatic Tissues: SNVs and SVs in Single Cells in the Brain, Blood and Beyond
Chair: Thomas E. Wilson, University of Michigan, USA

Managing Genes in Space
Chair: William K. Kaufmann, Retired, USA

Summary of Outcome from the International Workshop on Genotoxicity Testing. (The IWGT will precede the ICEM)
Chair: David Kirkland, Kirkland Consulting, UK

Transposon Genetics and Epigenetics in Exposure-Mediated Mutations
Chair: Chris Faulk, University of Minnesota, USA

Graham Walker Retirement Celebration: The History and Future of Mismatch Repair
Chair: Cilla Cooper, University of California, Berkeley, USA